Device Trial Radar · NCT03465904
A Phase III Trial of e-TNS for the Acute Treatment of Migraine
Last checked: Nov 19, 2026Latest source record: Dec 11, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
607
Actual
Start
Apr 10, 2018
Primary completion
Jan 11, 2019
Study completion Jan 11, 2019
Sponsor
- Lead sponsor
- Cefaly TechnologyNot on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 14, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main objective of this study is to have Phase III evidences of the efficacy of the Cefaly® Abortive Program device used at home for 2 hours to treat a migraine attack. This randomized, double-blind, sham-controlled trial will study the abortive treatment of migraine using the Cefaly® Abortive Program device.
Conditions
- Migraine
Interventions
Verum Cefaly® Abortive Program deviceDevice
The Cefaly® Abortive Program device is an external cranial neurostimulator designed for supraorbital neurostimulation, also known as external Trigeminal Nerve Stimulation (e-TNS). The Verum Cefaly® Abortive Program device will deliver verum external trigeminal nerve stimulation.
Sham Cefaly® Abortive Program deviceDevice
The Cefaly® Abortive Program device is an external cranial neurostimulator designed for supraorbital neurostimulation, also known as external Trigeminal Nerve Stimulation (e-TNS). The Sham Cefaly® Abortive Program device will deliver sham external trigeminal nerve stimulation.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pain Freedom at 2 HoursTime frame: 2 hours
- Most Bothersome Migraine-associated Symptom Freedom at 2 HoursTime frame: 2 hours
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
Clinical Research Consortium
Tempe, Arizona
Pharmacology Research Institute
Encino, California
Yale University
New Haven, Connecticut
7 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.